Myomectomy
Latest News
Despite effective therapies, fibroid care still lacking
The biggest challenge is to ensure that women can take advantage of the newer minimally invasive therapies.
Clinical Review
Fibroids: Growing management options for a prevalent problem
Reproductive Rounds
Fibroids: Is surgery the only management approach?
The current literature cannot conclude that fibroids reduce the likelihood of achieving pregnancy with or without fertility treatment based on a...
Expert Commentary
Closing the racial gap in minimally invasive gyn hysterectomy and myomectomy
Providing equitable care calls for research, education, training, and targeted quality improvements
The historical...
Product Review
FDA and power morcellation, gel for vaginal odor, and an intrauterine electrosurgery system
FDA and power morcellation, gel for vaginal odor, and an intrauterine electrosurgery system
FDA guidance for...
From the Editor
Cesarean myomectomy: Safe operation or surgical folly?
In many countries cesarean myomectomy is now viewed as a safe and effective procedure in carefully selected clinical situations
News for Your Practice
Prophylactic antibiotics for myomectomy?
ACOG does not currently recommend antibiotics for myomectomy procedures. A retrospective study adds to the evidence, however,...
Surgical Techniques
Hysteroscopy and COVID-19: Have recommended techniques changed due to the pandemic?
Be cognizant to follow these recommendations for minimizing the risk of viral spread during hysteroscopic procedures
From the Editor
New hormonal medical treatment is an important advance for AUB caused by uterine fibroids
Women with fibroids causing symptomatic abnormal uterine bleeding who choose to avoid a therapeutic procedure have a new hormonal treatment option...
Expert Commentary
How effective is elagolix treatment in women with fibroids and HMB?
Elagolix with hormonal add-back therapy (estradiol/norethindrone) was effective: 87.9% of participants who received...
Expert Commentary
Can a drug FDA approved for endometriosis become a mainstay for nonsurgical treatment of HMB in women with fibroids?
Elagolix is a GnRH antagonist that is approved in a 2-dose schedule for treatment of endometriosis. It is given...